Prostate Disease Clinical Trial
Official title:
Pilot Study to Evaluate In Vivo Plastic Scintillation Detectors for Real-Time Radiation Dosimetry During Prostate Cancer Radiotherapy
The goal of this clinical research study is to learn if a rectal balloon with attached radiation detectors can be used to help researchers monitor the dose of external beam radiation that is delivered to the prostate during treatment. This may help researchers better understand the side effects of radiation therapy, such as rectal bleeding, and may lead to changes in treatment planning or treatment delivery.
As a part of your standard of care, you will have external beam radiation therapy. You will
have a computerized tomography (CT) scan of the pelvis before the external beam radiation
therapy.
For the CT scan, you will be given an enema to empty your bowel, and you will drink about 16
to 24 ounces of water to fill your bladder
A rectal balloon will then be inserted into your rectum and filled with either air or water.
You will then have the CT scan. The CT scan should take about 45 minutes.
If you agree to take part in this study, very thin (millimeter-sized) radiation detectors
will be attached to the rectal balloon during each of two CT scans per week you will have
while you are receiving radiation. You may have additional CT scans (without the detector)
each week if your doctor thinks it is needed.
The doses read by the radiation detectors will be compared to the doses that you were
originally scheduled to receive after each radiation treatment and at the end of the study.
You will be off study after your final radiation treatment using the rectal balloon.
This is an investigational study. Up to 15 patients will take part in this study. All will
be enrolled at MD Anderson.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04288427 -
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
|
N/A | |
Completed |
NCT00756561 -
HOP-2A - Intratesticular Hormone Levels
|
N/A | |
Enrolling by invitation |
NCT03503643 -
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
|
||
Active, not recruiting |
NCT03543189 -
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03658408 -
4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy
|
Phase 2 | |
Recruiting |
NCT04656678 -
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer
|
N/A | |
Recruiting |
NCT04026763 -
MR/TRUS Fusion Guided Prostate Biopsy
|
N/A | |
Completed |
NCT05834270 -
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
|
N/A | |
Completed |
NCT00037141 -
Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT03589196 -
Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT
|
N/A | |
Recruiting |
NCT05902637 -
The Efficacy Of Mapping For Cognitive Prostate Biopsy
|
N/A | |
Withdrawn |
NCT03597386 -
ConfirmMDx Assay in Multiparametric MRI (mpMRI) PIRADS Scored Lesions After a Negative MR/US Fusion Biopsy
|
||
Completed |
NCT05399940 -
The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters
|
||
Withdrawn |
NCT04699552 -
Effect of Laser Settings on Postoperative Voiding Symptoms in Patients Undergoing Holmium Laser Enucleation of the Prostate
|
N/A | |
Active, not recruiting |
NCT05682742 -
Clinical Investigation of the da Vinci Surgical System
|
N/A | |
Completed |
NCT05803096 -
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
|
Phase 4 | |
Recruiting |
NCT04599218 -
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
|
N/A | |
Not yet recruiting |
NCT05470127 -
Evaluation of a Soft Tissue Biopsy System for Trans-rectal and Trans-perineal Biopsy of the Prostate
|
N/A |